Kura Oncology (KURA) Earnings Date & Reports

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

KURA is expected to report earnings to rise 182.68% to -62 cents per share on May 01

Kura Oncology KURA Stock Earnings Reports

Q1'25

Est.

$-0.62

Q4'24

Beat

by $0.35

Q3'24

Est.

$-0.63

Q2'24

Beat

by $0.04

Q1'24

Missed

by $0.04

The last earnings report on February 26 showed earnings per share of -21 cents, beating the estimate of -56 cents. With 50.98K shares outstanding, the current market capitalization sits at 509.71M.

View a ticker or compare two or three

Compare

KURA